Couttas, Timothy A., Boost, Carola, Pahlisch, Franziska, Sykorova, Eliska B., Leweke, Judith E., Koethe, Dagmar, Endepols, Heike, Rohleder, Cathrin ORCID: 0000-0002-3559-1846 and Leweke, F. Markus ORCID: 0000-0002-8163-195X . Simultaneous Assessment of Serum Levels and Pharmacologic Effects of Cannabinoids on Endocannabinoids and N-Acylethanolamines by Liquid Chromatography-Tandem Mass Spectrometry. Cannabis Cannabinoid Res.. NEW ROCHELLE: MARY ANN LIEBERT, INC. ISSN 2378-8763

Full text not available from this repository.

Abstract

Introduction: The primary compounds of Cannabis sativa, delta-9-tetrahydrocannabinol (Delta(9)-THC) and cannabidiol (CBD), inflict a direct influence on the endocannabinoid system-a complex lipid signaling network with a central role in neurotransmission and control of inhibitory and excitatory synapses. These phytocannabinoids often interact with endogenously produced endocannabinoids (eCBs), as well as their structurally related N-acylethanolamines (NAEs), to drive neurobiological, nociceptive, and inflammatory responses. Identifying and quantifying changes in these lipid neuromodulators can be challenging owing to their low abundance in complex matrices. Materials and Methods: This article describes a robust liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the extraction and quantification of the eCBs anandamide and 2-arachidonoylglycerol, along with their congener NAEs oleoylethanolamine and palmitoylethanolamine, and phytocannabinoids CBD, Delta(9)-THC, and 11-Nor-9-carboxy-Delta(9)-tetrahydrocannabinol, a major metabolite of Delta(9)-THC. Our method was applied to explore pharmacokinetic and pharmacodynamic effects from intraperitoneal injections of Delta(9)-THC and CBD on circulating levels of eCBs and NAEs in rodent serum. Results: Detection limits ranged from low nanomolar to picomolar in concentration for eCBs (0.012-0.24 pmol/mL), NAEs (0.059 pmol/mL), and phytocannabinoids (0.24-0.73 pmol/mL). Our method displayed good linearity for calibration curves of all analytes (R-2 > 0.99) as well as acceptable accuracy and precision, with quality controls not deviating > 15% from their nominal value. Our LC-MS/MS method reliably identified changes to these endogenous lipid mediators that followed a causal relationship, which was dependent on both the type of phytocannabinoid administered and its pharmaceutical preparation. Conclusion: We present a rapid and reliable method for the simultaneous quantification of phytocannabinoids, eCBs, and NAEs in serum using LC-MS/MS. The accuracy and sensitivity of our assay infer it can routinely monitor endogenous levels of these lipid neuromodulators in serum and their response to external stimuli, including cannabimimetic agents.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Couttas, Timothy A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Boost, CarolaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Pahlisch, FranziskaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sykorova, Eliska B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Leweke, Judith E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Koethe, DagmarUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Endepols, HeikeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rohleder, CathrinUNSPECIFIEDorcid.org/0000-0002-3559-1846UNSPECIFIED
Leweke, F. MarkusUNSPECIFIEDorcid.org/0000-0002-8163-195XUNSPECIFIED
URN: urn:nbn:de:hbz:38-689375
DOI: 10.1089/can.2021.0181
Journal or Publication Title: Cannabis Cannabinoid Res.
Publisher: MARY ANN LIEBERT, INC
Place of Publication: NEW ROCHELLE
ISSN: 2378-8763
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
ENDOGENOUS CANNABINOIDS; CEREBROSPINAL-FLUID; ANANDAMIDE; QUANTIFICATION; PALMITOYLETHANOLAMIDE; RECEPTOR; PLASMA; BRAIN; BLOOD; DELTA(9)-TETRAHYDROCANNABINOLMultiple languages
Pharmacology & PharmacyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/68937

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item